goBalto Closes $12M Venture Funding

goBalto, Inc., a San Francisco, CA-based developer of cloud solutions that are designed to simplify how clinical trials are conducted, has closed a $12m venture funding.

The round was led by EDBI, with participation from new investor Qualcomm Life Fund, which is managed by Qualcomm Ventures, as well as existing investors Aberdare Ventures, West Health Investment Fund, and Founding CEO Jae Chung.

The new funding, which brings goBalto’s total financing to $21m, will be used to enhance the company’s platform for clinical study startup with new product capabilities that will help support the demands of the growing clinical research market.

Founded 2008 in Silicon Valley, goBalto’s flagship product, Tracker, is a software-as-a-service clinical research tool, which enables clinical trial sponsors and research organizations to track and collaborate on operational data in a transparent, regulatory-compliant, and user-friendly way.



Join the discussion